Cargando…
You & Me: Test and Treat study protocol for promoting COVID-19 test and treatment access to underserved populations
BACKGROUND: Infections and deaths from the COVID-19 pandemic have disproportionately affected underserved populations. A community-engaged approach that supports decision making around safe COVID-19 practices is needed to promote equitable access to testing and treatment. You & Me: Test and Trea...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612258/ https://www.ncbi.nlm.nih.gov/pubmed/37898741 http://dx.doi.org/10.1186/s12889-023-16960-6 |
_version_ | 1785128663059005440 |
---|---|
author | D’Agostino, Emily M. Rosenberg, Lauren M. Richmond, Alan Damman, Allyn Brown-Lowery, Camille Abbot-Grimes, Princess Siddiqui, Saira Fadika, Tigidankay Ward, Mark Cooper, Mia Sutton, Sonya Kenton, Lindsay Spaziano, Bob Kasper, Janet Barnes, Nicole Hornik, Christoph |
author_facet | D’Agostino, Emily M. Rosenberg, Lauren M. Richmond, Alan Damman, Allyn Brown-Lowery, Camille Abbot-Grimes, Princess Siddiqui, Saira Fadika, Tigidankay Ward, Mark Cooper, Mia Sutton, Sonya Kenton, Lindsay Spaziano, Bob Kasper, Janet Barnes, Nicole Hornik, Christoph |
author_sort | D’Agostino, Emily M. |
collection | PubMed |
description | BACKGROUND: Infections and deaths from the COVID-19 pandemic have disproportionately affected underserved populations. A community-engaged approach that supports decision making around safe COVID-19 practices is needed to promote equitable access to testing and treatment. You & Me: Test and Treat (YMTT) will evaluate a systematic and scalable community-engaged protocol that provides rapid access to COVID-19 at-home tests, education, guidance on next steps, and information on local resources to facilitate treatment in underserved populations. METHODS: This direct-to-participant observational study will distribute at-home, self-administered, COVID-19 testing kits to people in designated communities. YMTT features a Public Health 3.0 framework and Toolkit prescribing a tiered approach to community engagement. We will partner with two large community organizations, Merced County United Way (Merced County, CA) and Pitt County Health Department (Pitt County, NC), who will coordinate up to 20 local partners to distribute 40,000 COVID tests and support enrollment, consenting, and data collection over a 15-month period. Participants will complete baseline questions about their demographics, experience with COVID-19 infection, and satisfaction with the distribution event. Community partners will also complete engagement surveys. In addition, participants will receive guidance on COVID-19 mitigation and health-promoting resources, and accessible and affordable therapeutics if they test positive for COVID-19. Data collection will be completed using a web-based platform that enables creation and management of electronic data capture forms. Implementation measures include evaluating 1) the Toolkit as a method to form community-academic partnerships for COVID-19 test access, 2) testing results, and 3) the efficacy of a YMTT protocol coupled with local resourcing to provide information on testing, guidance, treatment, and links to resources. Findings will be used to inform innovative methods to address community needs in public health research that foster cultural relevance, improve research quality, and promote health equity. DISCUSSION: This work will promote access to COVID-19 testing and treatment for underserved populations by leveraging a community-engaged research toolkit. Future dissemination of the toolkit can support effective community-academic partnerships for health interventions in underserved settings. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05455190. Registered 13 July 2022. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-16960-6. |
format | Online Article Text |
id | pubmed-10612258 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106122582023-10-29 You & Me: Test and Treat study protocol for promoting COVID-19 test and treatment access to underserved populations D’Agostino, Emily M. Rosenberg, Lauren M. Richmond, Alan Damman, Allyn Brown-Lowery, Camille Abbot-Grimes, Princess Siddiqui, Saira Fadika, Tigidankay Ward, Mark Cooper, Mia Sutton, Sonya Kenton, Lindsay Spaziano, Bob Kasper, Janet Barnes, Nicole Hornik, Christoph BMC Public Health Study Protocol BACKGROUND: Infections and deaths from the COVID-19 pandemic have disproportionately affected underserved populations. A community-engaged approach that supports decision making around safe COVID-19 practices is needed to promote equitable access to testing and treatment. You & Me: Test and Treat (YMTT) will evaluate a systematic and scalable community-engaged protocol that provides rapid access to COVID-19 at-home tests, education, guidance on next steps, and information on local resources to facilitate treatment in underserved populations. METHODS: This direct-to-participant observational study will distribute at-home, self-administered, COVID-19 testing kits to people in designated communities. YMTT features a Public Health 3.0 framework and Toolkit prescribing a tiered approach to community engagement. We will partner with two large community organizations, Merced County United Way (Merced County, CA) and Pitt County Health Department (Pitt County, NC), who will coordinate up to 20 local partners to distribute 40,000 COVID tests and support enrollment, consenting, and data collection over a 15-month period. Participants will complete baseline questions about their demographics, experience with COVID-19 infection, and satisfaction with the distribution event. Community partners will also complete engagement surveys. In addition, participants will receive guidance on COVID-19 mitigation and health-promoting resources, and accessible and affordable therapeutics if they test positive for COVID-19. Data collection will be completed using a web-based platform that enables creation and management of electronic data capture forms. Implementation measures include evaluating 1) the Toolkit as a method to form community-academic partnerships for COVID-19 test access, 2) testing results, and 3) the efficacy of a YMTT protocol coupled with local resourcing to provide information on testing, guidance, treatment, and links to resources. Findings will be used to inform innovative methods to address community needs in public health research that foster cultural relevance, improve research quality, and promote health equity. DISCUSSION: This work will promote access to COVID-19 testing and treatment for underserved populations by leveraging a community-engaged research toolkit. Future dissemination of the toolkit can support effective community-academic partnerships for health interventions in underserved settings. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05455190. Registered 13 July 2022. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-16960-6. BioMed Central 2023-10-28 /pmc/articles/PMC10612258/ /pubmed/37898741 http://dx.doi.org/10.1186/s12889-023-16960-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Study Protocol D’Agostino, Emily M. Rosenberg, Lauren M. Richmond, Alan Damman, Allyn Brown-Lowery, Camille Abbot-Grimes, Princess Siddiqui, Saira Fadika, Tigidankay Ward, Mark Cooper, Mia Sutton, Sonya Kenton, Lindsay Spaziano, Bob Kasper, Janet Barnes, Nicole Hornik, Christoph You & Me: Test and Treat study protocol for promoting COVID-19 test and treatment access to underserved populations |
title | You & Me: Test and Treat study protocol for promoting COVID-19 test and treatment access to underserved populations |
title_full | You & Me: Test and Treat study protocol for promoting COVID-19 test and treatment access to underserved populations |
title_fullStr | You & Me: Test and Treat study protocol for promoting COVID-19 test and treatment access to underserved populations |
title_full_unstemmed | You & Me: Test and Treat study protocol for promoting COVID-19 test and treatment access to underserved populations |
title_short | You & Me: Test and Treat study protocol for promoting COVID-19 test and treatment access to underserved populations |
title_sort | you & me: test and treat study protocol for promoting covid-19 test and treatment access to underserved populations |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612258/ https://www.ncbi.nlm.nih.gov/pubmed/37898741 http://dx.doi.org/10.1186/s12889-023-16960-6 |
work_keys_str_mv | AT dagostinoemilym youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations AT rosenberglaurenm youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations AT richmondalan youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations AT dammanallyn youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations AT brownlowerycamille youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations AT abbotgrimesprincess youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations AT siddiquisaira youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations AT fadikatigidankay youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations AT wardmark youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations AT coopermia youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations AT suttonsonya youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations AT kentonlindsay youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations AT spazianobob youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations AT kasperjanet youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations AT barnesnicole youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations AT hornikchristoph youmetestandtreatstudyprotocolforpromotingcovid19testandtreatmentaccesstounderservedpopulations |